Злокачественные опухоли кожи: литература
Albert L et al: Dysplastic melanocytic nevi and cutaneous melanoma: Markers of increased melanoma risk for affected individuals and blood relatives. J Am Acad Dermatol 7:69, 1990
Armstrong BK: Epidemiology of malignant melanoma: Intermittent or total accumulated exposure to the sun. J Dermatol Surg Oncol 14:835, 1988
Balch CM et al. (eds): Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide, 2d ed. Philadelphia, Lippincott, 1992
Balch CM et al: Efficacy of 2-cm surgical margins for intermediate- thickness melanomas (1.4 mm). Ann Surg 218:262, 1993
Boon T: Tumor antigens recognized by cytolytic Т lymphocytes present perspectives for specific immunotherapy. Int J Cancer 54:177, 1993
Clark WH Jr et al: The histogenesis and biologic behavior of primary human malignant melanoma of the skin. Cancer Res 29:705, 1969
Creagan ET et al: Randomized surgical adjuvant clinical trial of recombinant interferon-alfa-2a in selected patients with malignant melanoma. J Clin Oncol 13:2776, 1995
Drake LA et al: Guidelines of care for cutaneous squamous cell carcinoma. J Am Acad Dermatol 28:628, 1993
Drake LA et al: Guidelines of care of basal cell carcinoma. J Am Acad Dermatol 26:117,1992
Friedman RJ et al. (eds): Cancer of the Skin. Philadelphia, Saun ders, 1991, pp 27-94
Friedman RJ et al: Malignant melanoma in the 1990s: The continued importance of early detection and the role of physician examination and self-examination of the skin. CA 41:201, 1991
Johnson TM et al: Current therapy for cutaneous melanoma. J Am Acad Dermatol 32:689,1995
Koh HK: Cutaneous melanoma. N Engl J Med 325:171,1991
Kwa RE: Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 26:1,1992
Lippman SM et al: 13cis-retinoic acid and interferon-<x2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 84:235, 1992
Marks R: An overview of skin cancers. Incidence and causation. Cancer 75(Suppl):607,1995
Preston DS et al: Nonmelanoma cancer of the skin. N Engl J Med 327:1649, 1992
Rhodes AR et al: Risk factors for cutaneous melanoma. JAMA 258:3146, 1987
Rhodes AR: Neoplasms: Benign neoplasias, hyperplasias, and dysplasias of melanocytes, in Dermatology in General Medicine, 4th ed., ТВ Fitzpatricketal. (eds). New York, McGraw-Hffl, 1993, pp 996-1097
Rigel DS et al: Dysplastic nevi. Markers for increased risk for melanoma. Cancer 63:386,1989
Rosenberg SA: The immunotherapy and gene therapy of cancer. J ClinOncollO:180, 1992
Veronesi U et al: Delayed regional lymph node dissection in stage 1 melanoma of the skin of the lower extremities. Cancer 49:2420,1982
Veronesi U, Cancinelli N: Narrow excision (1 cm margin), a safe procedure for thin cutaneous melanoma. Arch Surg 126:438, 1991
